Private Market View

NeuroGen Pharma

Buildings and Property

Last price · $/share
Implied valuation
Total raised
$680.0M
Last round
Buyout/LBO
Nov 2024
Investors — not yet on record

No investors in NeuroGen Pharma are on record yet. Backers surface from round announcements, filings, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·Watchlist + deal alerts for NeuroGen Pharma
Create free account
No card required